Similar Papers

Paper Title
Journal
Date
Author
3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR Tcells.
Zhiqiang Wang ...
Cell Stem Cell | VOL. 29
Zhiqiang Wang, et. al.Zhiqiang Wang ...
01 Apr 2022
Development and Validation of a Clinical Prediction Model for the Efficacy of CD19 CAR T-Cell Therapy in DLBCL
Bin Xue ... Xiu Luo
Blood | VOL. 142
Bin Xue, et. al.Bin Xue ... Xiu Luo
02 Nov 2023
Rreal-World Results from Anti-CD19 CAR-T Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Spain and Comparison with Previous Standard of Care: A Geltamo/Geth Study
...
Blood | VOL. 138
, et. al. ...
05 Nov 2021
Zanubrutinib Combined Regimen As Bridging Treatment on Promising Clinical Outcome of CD19 Chimeric Antigen Receptor T-Cell Therapies in Relapsed or Refractory Large B-Cell Lymphoma
Yan Lu ... Aibin Liang
Blood | VOL. 142
Yan Lu, et. al.Yan Lu ... Aibin Liang
28 Nov 2023
View more papers

More From: Chinese medical journal

Paper Title
Journal
Date
Author
Neuroprotective effects of hypidone hydrochloride (YL-0919) after traumatic brain injury in mice.
Yue Zhang ... Yunfeng Li
Chinese medical journal | VOL. -
Yue Zhang, et. al.Yue Zhang ... Yunfeng Li
14 Jan 2025
Gut microbiota and their metabolites in hemodialysis patients.
Junxia Du ... Hanyu Zhu
Chinese medical journal | VOL. -
Junxia Du, et. al.Junxia Du ... Hanyu Zhu
14 Jan 2025
Treatment efficacy for relapsed/refractory multiple myeloma patients with gain/amplification 1q21.
Xia Zhou ... Yuping Zhong
Chinese medical journal | VOL. -
Xia Zhou, et. al.Xia Zhou ... Yuping Zhong
14 Jan 2025
Assessment of genetic associations between antidepressant drug targets and various stroke subtypes: A Mendelian randomization approach
Luyang Zhang ... Daishi Tian
Chinese Medical Journal | VOL. -
Luyang Zhang, et. al.Luyang Zhang ... Daishi Tian
07 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.